2-Amino-6-(1-methyl-1H-1,2,4-triazol-3-yl)-phenol
- CAS
- 3026065-02-8
- Formula
- C9H10N4O
- MW
- 190.2 g/mol
VQ-036645
Impurity reference standards
Deucravacitinib impurities & reference standards
Characterised Deucravacitinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
28reference materials
COAHPLC · NMR · MS on request
Parent API: Deucravacitinib
1609392-27-9 · C20H22N8O3
3-(1-Ethyl-1H-1,2,4-triazol-3-yl)-2-methoxyaniline
- CAS
- 2948391-22-6
- Formula
- C11H14N4O
- MW
- 218.26 g/mol
VQ-030145
3-(2-Methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole
- CAS
- 1609394-08-2
- Formula
- C10H10N4O3
- MW
- 234.21 g/mol
VQ-025267
3-(3-Bromo-2-methoxyphenyl)-1-methyl-1H-1,2,4-triazole
- CAS
- 2222717-56-6
- Formula
- C10H10BrN3O
- MW
- 268.11 g/mol
VQ-035377
4-Chloro-6-hydroxypyridazine-3-carboxylic acid
- CAS
- 1782896-18-7
- Formula
- C5H3ClN2O3
- MW
- 174.54 g/mol
VQ-030147
6-Amino-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic Acid
- CAS
- 3030727-66-0
- Formula
- C15H15N7O3
- MW
- 341.32 g/mol
VQ-036651
N-(5-((2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazin-3-yl)cyclopropanecarboxamide
- CAS
- 3030723-95-3
- Formula
- C18H19N7O2
- MW
- 365.4 g/mol
VQ-036647
FAQs — Deucravacitinib impurities
Which Deucravacitinib impurities do you supply?
We list 28 Deucravacitinib-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Deucravacitinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Deucravacitinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Deucravacitinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.